LCTX on the weekly chart here has been falling since late 2021 and found support at the bottom
of the high volume area of the volume profile and ranged between it and the POC line for the
past 18 months. The is a high end clinically active biotechnology firm using stem cells to
produce therapeutic cell lines . ( One experiment using the mammary glands of...
VINC on the 15 minute chart was sideways at the top and put in a 20% short trade today which
was straightforward an easy. A 50% partial taken off at the mid-day counter trend then the
remainder of 50% off before the close. Idea is on the chart; see also the previous ideas.
Expecting a full reversal in the pre-market trading and a good intraday trade at least...
TSHA is a gene technology medical company which reported on its clinical trials for Rett
Syndrome which is a neurobehavioral disorder separate from others like autism or
schizophrenia. This could be a breakthrough medication for those who suffer from Rett.
TSHA102 could be heralded as a miracle treatment ( not a cure). Price had trended up
in February and...
MRNA focuses on vaccine research and development and we are in the flu season an COVID is
lurking in the shadows and trying to make a comback. It had an excellent earnings report and
forward guidance. On the 60 minute chart, price has bounced up from a test of the anchored
VWAP and is at the level of the first upper VWAP while in side the high volume area...
NVAX on the 15 minute chart has been compressing price action volatility into a symmetrical
triangle. It in now in a breakout of the triangle and in the process when from undervalued on
Monday to the upper trendline and then down to the support trendline and then up again.
It passed through the volume profile and its high volume area. In short, it has bullish...
SRZN ona 30 minute chart is on a consistent trend up for three weeks with some minor normal
corrections while underway. Now is one of those pullbacks waiting for an entry.
Price is getting support from the first upper VWAP bandline confluent with the lower ascending
support line of the megaphone pattern. A megaphone pattern documents increasing volatility
in...
On the weekly chart a LABU / LABD ratio is plotted with anchored VWAP bands and a volume
profile overlaid. I wanted to analyze this to affirm the highest of prospects for the
Biotechnology sector for 2024. LABU is triple leveraged Up while LABD is the inverse Down.
A good unleveraged biotech ETF is XBI. The chart shows LABU in a VWAP band and breakout ...
ZBH is a big global medical device company. It is old school. Aluminum titanium polymers, plates screws wires. Hollywood stars are familiar as it makes the devices for leg lengthening surgery. ( shortening is easy, lengthening not so much) I am familiar because in the past I have served as a consultant for this company. It business is mainly orthopedic elective...
LABU over the past ten trading days has trended down from the top of the volume profile
to near the bottom. The Price-volume trend is flat showing accumulation/coiling.
The price momentum oscillator shows an uptrend suggestive of bullish divergence and
the volumes are stable at or above the running mean. I see this as a good long trade
as some if the ETF...
